Rocket Pharmaceuticals

RCKTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$367.745 M

$3.35 +2.45%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$223.1M

Loss-making

Shares outstanding

109,774,597

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#225Benitec BiopharmaBNTC$382.0M
#226BridgeBio Oncology TherapeuticsBBOT$373.6M
#227Rocket PharmaceuticalsRCKT$367.7M
#228Enanta PharmaceuticalsENTA$361.7M
#229EvommuneEVMN$348.4M

What if Rocket Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$275,418.64

Per share 82,215× higher

Bitcoin $1.74T

$15,865.74

Per share 4,736× higher

Nvidia $5.52T

$50,246.30

Per share 14,999× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Rocket Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.